BioSpace News Archive

Myomo, Inc. announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering.

Solid Biosciences (Nasdaq:SLDB) announced today preliminary findings from IGNITE DMD, the Company’s Phase I/II dose-ascending clinical trial evaluating the safety and efficacy of SGT-001 microdystrophin gene transfer for the treatment of Duchenne muscular dystrophy (DMD). Initial three-month biopsy data showed low levels of microdystrophin protein expression.

The Angiogenesis Foundation commented on the EAT-Lancet Commission’s ‘planetary health diet,’ which was presented by Harvard Professor Walter Willett at the United Nations in New York City on February 5, 2019.

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, will participate in the Guggenheim Healthcare Talks Idea Forum & Oncology Day in New York on Thursday, February 14th at 11:00 a.m. ET/ 8:00 a.m. PT.

For more than three decades, American Skin Association (ASA) and its affiliates have funded more than $50 million in grants to address the causes and treatments of melanoma, vitiligo, and psoriasis, as well as other skin diseases, and to search for much-needed cures.

Aurora Cannabis Inc. announced a confirmed time for its scheduled conference call to discuss the results for its second quarter ended December 31, 2018.

This year’s International IP Index from The Global IP Center reflects the important progress being made at the U.S. Patent & Trademark Office under the leadership of Director Andrei Iancu.

Company to Host Conference Call on Thursday, February 21, 2019 at 1:30 p.m. PT / 4:30 p.m. ET

She may be five foot three and 110 pounds soaking wet, but Dr. Kathleen Weber of Midwest Orthopaedics at Rush (MOR) can get a 250-pound outfielder and 6' 9" forward to confide in her about their health concerns.

CVD Equipment Corporation announced that Thomas McNeill has been appointed as Chief Financial Officer and Secretary, effective March 4, 2019.